Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 161Squamous Cell Carcinoma of Head and Neck 95Head and Neck Neoplasms 95Colonic Neoplasms 46Rectal Neoplasms 39Neoplasm Metastasis 35Carcinoma, Non-Small-Cell Lung 29Carcinoma, Squamous Cell 25Pancreatic Neoplasms 18Neoplasms 18Esophageal Neoplasms 18Lung Neoplasms 17Stomach Neoplasms 13Laryngeal Neoplasms 12Recurrence 11Oropharyngeal Neoplasms 11Mouth Neoplasms 11Esophageal Squamous Cell Carcinoma 11Colorectal Cancer Metastatic 10Tongue Neoplasms 9Carcinoma 9Breast Neoplasms 9Nasopharyngeal Carcinoma 8Hypopharyngeal Neoplasms 8Adenocarcinoma Of Esophagus 8Laryngeal Diseases 6Salivary Gland Neoplasms 5Neoplasms, Squamous Cell 5Glioblastoma 5Uterine Cervical Neoplasms 4

Interventions

Docetaxel 7Radiotherapy 4Radiotherapy, Intensity-Modulated 3Filgrastim 3Cisplatin 3Paclitaxel 2Gemcitabine 2Etoposide 2Chemotherapy, Adjuvant 2Capecitabine 2tanespimycin 1sargramostim 1pentetreotide 1olaparib 1oblimersen 1lutetium Lu 177 dotatate 1etoposide phosphate 1apatinib 1X-Ray Therapy 1Therapeutics 1Thalidomide 1Surgical Procedures, Operative 1Semaxinib 1Salts 1SUB1 protein, human 1Protons 1Physical Therapy Modalities 1Photochemotherapy 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Esthesioneuroblastoma, Olfactory × Cetuximab × Clear all
NCT01637194 2012-07-11

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Fox Chase Cancer Center

Phase 1 Completed
12 enrolled
CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡